In 2015, we first reported on SAGE-547 (SAGE Therapeutics), a new medication for the treatment of severe postpartum depression (PPD). SAGE-547, now called brexanolone, is an allosteric modulator of GABA-A receptors. We saw the preliminary results of the Sage Therapeutics Phase 3 Hummingbird Program earlier this year. Now we have the final set of results… Read More »
Health trends over the decades can be puzzling when analyzed. It seems to be conflicting, developments make it difficult to understand where the future generations are striving in terms of overall health. With greater access to healthcare and new technology to fight crippling diseases in the past, it may seem that there is hope for… Read More »
Cancer is an abnormal cells which gets forms in a body.There are multiple types of cancers like Brain tumor, Breast cancer, Blood Cancer and many more. Nowadays, the technologies has been developed so much that, it can be cured if it is detected or it is checked as early as possible. Like through Radiation Therapy… Read More »
Almost everyone today wants a flawless skin and fine figure, but due to our lifestyle and changing environmental patterns, such wants are no less than an impossible dream. The constant stress takes a huge toll on you and your face and is seen in the guise of pimples, scar, blemishes, dark circles and a lot… Read More »
Sept. 28, 2018 — The FDA has approved the third of a new type of drug to prevent migraine headaches in adults. Galcanezumab-gnlm (Emgality) targets calcitonin gene-related peptide (CGRP), a molecule that’s produced in nerve cells of the brain and spinal cord. The FDA approved two other CGRP drugs for migraine — erenumab (Aimovig) and fremanezumab-vfrm… Read More »